Atlas Trials

A Study of TEPEZZA Subcutaneous Administration in Healthy Adults

Clinical trial NCT06563856 · COMPLETED

Trial details

NCT number
NCT06563856
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
BioavailabilityBioequivalence
Start date
2020-09-22
Primary completion
2021-05-27
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.